Literature DB >> 23754705

Worldwide trend of increasing primary adenocarcinoma of the lung.

Haruhiko Nakamura1, Hisashi Saji.   

Abstract

The four major histological types of lung cancer are adenocarcinoma, squamous cell carcinoma (SQ), large cell carcinoma and small cell carcinoma. Over the past few decades, the incidence of lung adenocarcinoma has increased gradually in most countries as the most frequently occurring histological type, displacing SQ. Adenocarcinoma is the predominant type of lung cancer among lifelong non-smokers and among females. Especially in East Asian countries, the cause(s) of the increase in adenocarcinomas are not clear. Several genetic mutations specific to lung adenocarcinomas have been found, representing attractive targets for molecular therapy. Recently, the pathological classification of lung adenocarcinoma was revised by integrating the newer clinical and biological knowledge concerning this prevailing type. Additional epidemiological, pathological and genetic studies are required to better understand this type of lung cancer.

Entities:  

Mesh:

Year:  2013        PMID: 23754705     DOI: 10.1007/s00595-013-0636-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  70 in total

Review 1.  Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysis.

Authors:  Haruhiko Nakamura; Koji Ando; Takuo Shinmyo; Katsuhiko Morita; Atsushi Mochizuki; Noriaki Kurimoto; Shinobu Tatsunami
Journal:  Ann Thorac Cardiovasc Surg       Date:  2011-07-27       Impact factor: 1.520

2.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

3.  Attributable and absolute risk of lung cancer death by smoking status: findings from the Japan Collaborative Cohort Study.

Authors:  Masahiko Ando; Kenji Wakai; Nao Seki; Akiko Tamakoshi; Koji Suzuki; Yoshinori Ito; Yoshikazu Nishino; Takaaki Kondo; Yoshiyuki Watanabe; Kotaro Ozasa; Yoshiyuki Ohno
Journal:  Int J Cancer       Date:  2003-06-10       Impact factor: 7.396

4.  Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.

Authors:  R Gealy; L Zhang; J M Siegfried; J D Luketich; P Keohavong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-04       Impact factor: 4.254

5.  Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study.

Authors:  Hiroyuki Sakurai; Hisao Asamura; Tomoyuki Goya; Kenji Eguchi; Yoichi Nakanishi; Noriyoshi Sawabata; Meinoshin Okumura; Etsuo Miyaoka; Yoshitaka Fujii
Journal:  J Thorac Oncol       Date:  2010-10       Impact factor: 15.609

6.  Risk factors for primary lung cancer among non-smoking women in Taiwan.

Authors:  Y C Ko; C H Lee; M J Chen; C C Huang; W Y Chang; H J Lin; H Z Wang; P Y Chang
Journal:  Int J Epidemiol       Date:  1997-02       Impact factor: 7.196

7.  What proportion of lung cancer in never-smokers can be attributed to known risk factors?

Authors:  Julia Sisti; Paolo Boffetta
Journal:  Int J Cancer       Date:  2012-03-27       Impact factor: 7.396

8.  Cigarette smoking and changes in the histopathology of lung cancer.

Authors:  M J Thun; C A Lally; J T Flannery; E E Calle; W D Flanders; C W Heath
Journal:  J Natl Cancer Inst       Date:  1997-11-05       Impact factor: 13.506

9.  Differences in lung cancer risk between men and women: examination of the evidence.

Authors:  E A Zang; E L Wynder
Journal:  J Natl Cancer Inst       Date:  1996-02-21       Impact factor: 13.506

10.  Cancer incidence in Asian migrants to New South Wales, Australia.

Authors:  A E Grulich; M McCredie; M Coates
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

View more
  39 in total

1.  Influence of smoking on perioperative oxidative stress after pulmonary resection.

Authors:  Yoshimasa Mizuno; Hisashi Iwata; Hirotaka Yamamoto; Yusaku Miyamoto; Shohei Mitta; Koyo Shirahashi; Hirofumi Takemura
Journal:  Surg Today       Date:  2015-02-21       Impact factor: 2.549

2.  Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma.

Authors:  Qingling Huang; Valentina E Schneeberger; Noreen Luetteke; Chengliu Jin; Roha Afzal; Mikalai M Budzevich; Rikesh J Makanji; Gary V Martinez; Tao Shen; Lichao Zhao; Kar-Ming Fung; Eric B Haura; Domenico Coppola; Jie Wu
Journal:  Mol Cancer Ther       Date:  2016-08-05       Impact factor: 6.261

Review 3.  Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS).

Authors:  Elizabeth R Tang; Andrew M Schreiner; Bradley B Pua
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

Review 4.  Clinical impact of the new IASLC/ATS/ERS lung adenocarcinoma classification for chest surgeons.

Authors:  Haruhiko Nakamura; Masayuki Takagi
Journal:  Surg Today       Date:  2014-11-23       Impact factor: 2.549

5.  Regulation of nonsmall-cell lung cancer stem cell like cells by neurotransmitters and opioid peptides.

Authors:  Jheelam Banerjee; Arokya M S Papu John; Hildegard M Schuller
Journal:  Int J Cancer       Date:  2015-07-02       Impact factor: 7.396

6.  DNA Methylation-Mediated Low Expression of CFTR Stimulates the Progression of Lung Adenocarcinoma.

Authors:  Yue Wang; Lu Tang; Liangliang Yang; Peiyun Lv; Shixiong Mai; Li Xu; Zhenxing Wang
Journal:  Biochem Genet       Date:  2021-09-08       Impact factor: 1.890

7.  Direct activation of PP2A for the treatment of tyrosine kinase inhibitor-resistant lung adenocarcinoma.

Authors:  Rita Tohmé; Sudeh Izadmehr; Sai Gandhe; Giancarlo Tabaro; Sanjay Vallabhaneni; Ava Thomas; Neal Vasireddi; Neil S Dhawan; Avi Ma'ayan; Neelesh Sharma; Matthew D Galsky; Michael Ohlmeyer; Jaya Sangodkar; Goutham Narla
Journal:  JCI Insight       Date:  2019-02-21

8.  MiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targeting TGFA gene expression.

Authors:  Haijian Wu; Yan Liu; Xiao Ou Shu; Qiuyin Cai
Journal:  Carcinogenesis       Date:  2016-03-31       Impact factor: 4.944

9.  IMP3 Predicts Invasion and Prognosis in Human Lung Adenocarcinoma.

Authors:  Jinhai Yan; Qingzhu Wei; Wenjing Jian; Bo Qiu; Jing Wen; Jianghuan Liu; Bo Fu; Xinhua Zhou; Tong Zhao
Journal:  Lung       Date:  2015-11-25       Impact factor: 2.584

10.  Current Trends of Carcinoma: Experience of a Tertiary Care Cancer Center in North India.

Authors:  Manjit K Rana; Tushar S Barwal; Uttam Sharma; Richika Bansal; Karuna Singh; Amrit Pal S Rana; Aklank Jain; Utkarshni Khera
Journal:  Cureus       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.